Triple
T1101303
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Committee for Medicinal Products for Veterinary Use |
E24385
|
entity |
| Predicate | location |
P40
|
FINISHED |
| Object | European Medicines Agency headquarters |
E3950
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Medicines Agency headquarters | Statement: [Committee for Medicinal Products for Veterinary Use, location, European Medicines Agency headquarters]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: European Medicines Agency headquarters Context triple: [Committee for Medicinal Products for Veterinary Use, location, European Medicines Agency headquarters]
-
A.
European Medicines Agency
chosen
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
B.
Paul Ehrlich Institute
The Paul Ehrlich Institute is Germany’s federal agency and research institution responsible for the evaluation, authorization, and monitoring of vaccines and biomedicines.
-
C.
Federal Institute for Drugs and Medical Devices
The Federal Institute for Drugs and Medical Devices is Germany’s central regulatory authority responsible for the authorization, safety monitoring, and risk assessment of pharmaceuticals and medical devices.
-
D.
AstraZeneca global corporate headquarters
AstraZeneca global corporate headquarters is the central administrative and research hub of the multinational pharmaceutical company AstraZeneca, located on the Cambridge Biomedical Campus in Cambridge, UK.
-
E.
EIT Headquarters
EIT Headquarters is the central administrative and coordination office of the European Institute of Innovation and Technology, overseeing its innovation, education, and entrepreneurship activities across Europe.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a4940542308190ac2a0b1f730b7cfc |
completed | March 1, 2026, 7:31 p.m. |
| NER | Named-entity recognition | batch_69a4b9c079f48190a0e0ddda182f7a01 |
completed | March 1, 2026, 10:12 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ac4c47dbf88190a1898d7bda32ecb2 |
completed | March 7, 2026, 4:03 p.m. |
Created at: March 1, 2026, 7:43 p.m.